Stocktoria
ALX ONCOLOGY HOLDINGS INC ALXO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-07-17
ALX ONCOLOGY HOLDINGS INC statistics & valuation
Market cap$274.5M
P / B10.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -172.2% | -91.3% | -66.3% | -40.3% | -22.0% |
| Return on equity | -391.4% | -118.7% | -84.8% | -46.9% | -23.0% |
| Debt / equity | 0.39× | 0.09× | 0.06× | 0.04× | — |
| Current ratio | 2.07 | 7.26 | 5.24 | 9.57 | 24.00 |
| Revenue growth | — | — | — | — | -100.0% |
Source: SEC EDGAR filings · CIK 0001810182 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.